Recognition highlights MadeAi’s use of AI to accelerate evidence generation while maintaining the scientific rigor, traceability, and human oversight required in life sciences
Cambridge, MA—September 10, 2026—MadeAi, the AI-enabled evidence synthesis provider for life sciences, today announced that it has been named the winner of the 2026 Fierce AI Innovation Award for AI Innovation in Medical Affairs.
The 2026 Fierce AI Innovation Awards recognize innovative applications of artificial intelligence across the life sciences industry.
MadeAi was recognized for its approach to one of the industry’s most demanding evidence challenges: accelerating literature review and evidence synthesis without sacrificing the transparency and scientific defensibility required for regulated life sciences workflows.
“Medical Affairs teams are being asked to interpret an extraordinary and growing volume of scientific evidence, while expectations for speed, accuracy, and transparency continue to rise,” said Gaugarin Oliver, Founder and CEO of MadeAi. “This award validates our belief that AI can fundamentally change how evidence is generated and used—not by removing scientific experts from the process, but by giving them a more powerful, traceable, and scalable way to work.”
MadeAi combines generative AI, large language models, natural language processing, retrieval-augmented generation, agentic AI, and human adjudication across the evidence synthesis workflow. The platform is designed to maintain source traceability and human review while automating labor-intensive activities including protocol development, screening, data extraction, synthesis, summarization, and reporting.
MadeAi demonstrates AI accuracy of more than 90%, providing time savings of 60% compared with traditional processes—all while maintaining human oversight that optimizes the time of busy Medical Affairs professionals.
MadeAi supports Medical Affairs, HEOR, Market Access, and RWE teams across pharmaceutical, medtech, and CRO organizations, helping them turn expanding volumes of scientific information into trusted, audit-ready evidence.
The recognition follows Fierce’s assessment of MadeAi as an AI-enabled, human-in-the-loop platform that automates labor-intensive literature review processes while maintaining scientific rigor and audit readiness at the center of the workflow.
About MadeAi
MadeAi™ is an AI-powered evidence synthesis and report generation platform purpose-built for life sciences. MadeAi is dedicated to accelerating systematic literature reviews, GVD and JCA submissions, and evidence generation workflows for pharmaceutical, biotech, and medical device organizations. From protocol to publication-ready deliverables, MadeAi offers both SaaS and full-service models, helping research teams achieve up to 60%-time savings and greater accuracy in their evidence programs.
Media Contact:
Meghan Oates-Zalesky
Chief Marketing Officer for MadeAi
Meghan.Oates@madeai.com
617-435-2470
